Transhumanism

U-Smell-It LLC Honored in Global $6M XPRIZE Rapid COVID Testing Competition

Retrieved on: 
Tuesday, March 16, 2021
Businesspeople, Non-profit organizations based in California, Transhumanism, X Prize Foundation, Corporate governance, Science and technology in the United States

GUILFORD, Conn., March 16, 2021 /PRNewswire/ -- U-Smell-It LLC, a Guilford-based company specializing in innovative COVID detection techniques, has announced that it has won the $6M XPRIZE Rapid COVID Testing, a global effort to develop breakthrough COVID testing methods.

Key Points: 
  • GUILFORD, Conn., March 16, 2021 /PRNewswire/ -- U-Smell-It LLC, a Guilford-based company specializing in innovative COVID detection techniques, has announced that it has won the $6M XPRIZE Rapid COVID Testing, a global effort to develop breakthrough COVID testing methods.
  • XPRIZE Rapid COVID Testing is a $6 million, six-month competition to develop faster, cheaper, and easier-to-use COVID-19 testing methods at scale.
  • "We are thrilled to announce the winners of the XPRIZE Rapid COVID Testing, which awarded multiple winners with unique testing solutions to help prevent future supply chain problems," said Anousheh Ansari, CEO of XPRIZE.
  • Active competitions include the $100 Million XPRIZE Carbon Removal with Elon Musk, $20 Million NRG COSIA Carbon XPRIZE, $15 Million XPRIZE Feed the Next Billion, $10 Million XPRIZE Rainforest, $10 Million ANA Avatar XPRIZE, $6 Million XPRIZE Rapid COVID Testing, $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling and $500,000 Pandemic Response Challenge.

Anti-Aging Market Revenue Worth $421.4 Billion by 2030: P&S Intelligence

Retrieved on: 
Monday, March 15, 2021
Ageing, Emerging technologies, Articles, Life extension, Population, Transhumanism, Time, Academic disciplines

During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.

Key Points: 
  • During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.
  • Due to the rising number of such conferences and seminars, the global anti-aging market is set to experience an 8.1% CAGR during 20202030, to grow from $191.5 billion in 2019 to $421.4 billion by 2030, according to P&S Intelligence.
  • This is because such events generally involve the launch and promotion of an array of devices and products by cosmetic and personal care companies.
  • Therefore, the anti-aging market is primarily advancing due to the rising awareness of consumers about the latest associated products available and under development.

Anti-Aging Market Revenue Worth $421.4 Billion by 2030: P&S Intelligence

Retrieved on: 
Monday, March 15, 2021
Ageing, Emerging technologies, Articles, Life extension, Population, Transhumanism, Time, Academic disciplines

During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.

Key Points: 
  • During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.
  • Due to the rising number of such conferences and seminars, the global anti-aging market is set to experience an 8.1% CAGR during 20202030, to grow from $191.5 billion in 2019 to $421.4 billion by 2030, according to P&S Intelligence.
  • This is because such events generally involve the launch and promotion of an array of devices and products by cosmetic and personal care companies.
  • Therefore, the anti-aging market is primarily advancing due to the rising awareness of consumers about the latest associated products available and under development.

Cover Technologies Provides Corporate Update

Retrieved on: 
Wednesday, March 10, 2021
Articles, Technology development, Bioethics, Emerging technologies, Technology forecasting, Transhumanism, Science and technology, Technology

VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) -- COVER TECHNOLOGIES INC. (CSE: COVE) (OTC: MGPRF) (Frankfurt: 304A) (the Company or Cover) is issuing this press release to provide an update on the trading halt initiated on March 4, 2021 at the request of the Company pending disclosure of material news.

Key Points: 
  • VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) -- COVER TECHNOLOGIES INC. (CSE: COVE) (OTC: MGPRF) (Frankfurt: 304A) (the Company or Cover) is issuing this press release to provide an update on the trading halt initiated on March 4, 2021 at the request of the Company pending disclosure of material news.
  • Cover believes that a technology of this nature would enable the Company to vertically integrate various levels of operations (i.e.
  • Cover Technologies Inc. is a technology research & development company with a focus on emerging technologies and solutions.
  • In addition to the current research and development on its magnesium processing technology, Cover Technologies is in pursuit of identifying opportunities in emerging technologies.

India’s HireMee among 10 qualified teams in $5 mn XPRIZE Rapid Reskilling Competition

Retrieved on: 
Wednesday, March 10, 2021
Software, Human resources, Health, Professional services, Technology, Education, Training, Other Health, Non-profit organizations based in California, Transhumanism, X Prize Foundation

Bengaluru-based job enablement platform Team HireMee has made it to the shortlist of 10 qualified teams in the prestigious $5 million XPRIZE Rapid Reskilling competition.

Key Points: 
  • Bengaluru-based job enablement platform Team HireMee has made it to the shortlist of 10 qualified teams in the prestigious $5 million XPRIZE Rapid Reskilling competition.
  • Launched in June 2020, XPRIZE Rapid Reskilling competition incentivizes teams to develop and demonstrate the effectiveness of a quick training and reskilling solution for individuals most vulnerable to employment loss in the United States.
  • The 10 qualified teams in the global competition were chosen following evaluation of 118 entries by a high-profile jury.
  • The 10 teams from 4 countries will now move to the Qualified Teams round of the $5 million XPRIZE Rapid Reskilling competition.

XPRIZE and Cognizant Announce Grand Prize Winners in Pandemic Response Challenge to Restart Economies Around the World

Retrieved on: 
Tuesday, March 9, 2021
Technology, Infectious diseases, Public relations, Investor relations, Communications, Clinical trials, Software, Health, General Health, Data management, Non-profit organizations based in California, Transhumanism, X Prize Foundation, Service companies, Cognizant

XPRIZE , the worlds leader in designing and operating incentive competitions to solve humanitys grand challenges, in partnership with Cognizant (Nasdaq: CTSH), one of the world's leading technology and professional services companies, today announced the Grand Prize Winners in the $500K Pandemic Response Challenge .

Key Points: 
  • XPRIZE , the worlds leader in designing and operating incentive competitions to solve humanitys grand challenges, in partnership with Cognizant (Nasdaq: CTSH), one of the world's leading technology and professional services companies, today announced the Grand Prize Winners in the $500K Pandemic Response Challenge .
  • "We are absolutely thrilled to announce the winners of the Pandemic Response Challenge, and are extremely grateful to Cognizant for their support during this competition, said Amir Banifatemi, Chief Innovation and Growth Officer of XPRIZE.
  • Active competitions include the $100M XPRIZE Carbon Removal, $20 Million NRG COSIA Carbon XPRIZE, $15M XPRIZE Feed the Next Billion, $10 Million XPRIZE Rainforest, $10 Million ANA Avatar XPRIZE, $6 Million XPRIZE Rapid COVID Testing, $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, and $500K Pandemic Response Challenge.
  • Headquartered in the U.S., Cognizant is ranked 194 on the Fortune 500 and is consistently listed among the most admired companies in the world.

AI/ML's CEO Appointed to Advisory Board of ST Innovations

Retrieved on: 
Tuesday, March 2, 2021
Articles, Bioethics, Emerging technologies, Technology development, Technology forecasting, Transhumanism, Science and technology, Technology

TORONTO, March 2, 2021 /PRNewswire/ --AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that Randy Duguay, CEO of AI/ML Innovations Inc. was appointed to the University of Alberta's ST Innovations Advisory Board in order to provide input and guidance regarding the commercialization of new technologies in the field of digital health innovations.

Key Points: 
  • TORONTO, March 2, 2021 /PRNewswire/ --AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that Randy Duguay, CEO of AI/ML Innovations Inc. was appointed to the University of Alberta's ST Innovations Advisory Board in order to provide input and guidance regarding the commercialization of new technologies in the field of digital health innovations.
  • "The addition of Randy Duguay to this prestigious advisory board is mutually beneficial" said Tim Daniels, Executive Chairman of AI/ML Innovations Inc. "Randy is able to share his wealth of expertise and experience in the field of digital health by mentoring and advising others, while simultaneously leveraging the human and technological resources of ST Innovations to the benefit of AI/ML Innovations."
  • ST Innovations, the business arm of the University of Alberta's SMART Network, is Alberta's leading R&D services organization, connecting entrepreneurs with world-class researchers in support of the latest innovation and R&D.
  • ( https://stinnovations.ca/ )
    For more information about AI/ML Innovations:

Parisa Khosropour Joins Advisory Board of Neuroenhancement Lab, Inc.

Retrieved on: 
Thursday, February 25, 2021
Transhumanism, Neuroenhancement, Parisa, Suffern, New York, Alexander I. Poltorak

SUFFERN, N.Y., Feb. 25, 2021 /PRNewswire-PRWeb/ --Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour Joined its Advisory Board.

Key Points: 
  • SUFFERN, N.Y., Feb. 25, 2021 /PRNewswire-PRWeb/ --Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour Joined its Advisory Board.
  • "We are very pleased to welcome Parisa to our advisory board," said Dr. Alexander Poltorak, Neuroenhancement Lab's Founder and President.
  • "I have dedicated my career to improving the lives of patients through innovation," said Parisa khosropour.
  • "I am delighted to join the Advisory Board of Neuroenhancement Labs, utilizing cutting edge technology for the treatment of neurologic diseases."

Aifred Health Named Top 3 Finalist in Global IBM Watson AI XPRIZE Competition

Retrieved on: 
Tuesday, February 16, 2021
Science and technology, Technology, Computing, Transhumanism, Non-profit organizations based in California, X Prize Foundation, Watson, Artificial intelligence, IBM

MONTREAL, Feb. 16, 2021 /PRNewswire/ - Aifred Health announced today that the XPRIZE jury has selected Aifred Health as one of the 3 finalists for the IBM Watson AI XPRIZE.

Key Points: 
  • MONTREAL, Feb. 16, 2021 /PRNewswire/ - Aifred Health announced today that the XPRIZE jury has selected Aifred Health as one of the 3 finalists for the IBM Watson AI XPRIZE.
  • Montreal-based Aifred Health was one of more than 700 applicants for this XPRIZE focused on employing AI to solve the world's grand challenges.
  • "To be named as one of the Top 3 global AI teams in the world is an incredible accomplishment and endorsement of our approach to better serving patients suffering from debilitating depression.
  • We are indebted to the XPRIZE organization and IBM Watson for their leadership and vision throughout the process.

Cover Technologies Inc. Announces a Non-Brokered Private Placement

Retrieved on: 
Friday, February 12, 2021
Articles, Bioethics, Emerging technologies, Technology development, Technology forecasting, Transhumanism, Science and technology, Technology

VANCOUVER, British Columbia, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cover Technologies Inc. (the Company or COVER) is pleased to announce that it intends to raise up to CDN $4,000,000 (the Financing) through a non-brokered private placement of up to 15,095,000 units (the Units) at a price of CDN $0.265 per Unit.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cover Technologies Inc. (the Company or COVER) is pleased to announce that it intends to raise up to CDN $4,000,000 (the Financing) through a non-brokered private placement of up to 15,095,000 units (the Units) at a price of CDN $0.265 per Unit.
  • Each Unit will consist of one common share in the capital of the Company (each a Share) and one share purchase warrant (each a Warrant).
  • Cover Technologies Inc. is a technology research & development company with a focus on emerging technologies and solutions.
  • In addition to the current research and development on its magnesium technology, Cover Technologies is in pursuit of identifying opportunities in emerging technologies.